2023
Scaling up evidence-based approaches to tuberculosis screening in prisons
Charalambous S, Velen K, Rueda Z, Croda J, Herce M, Shenoi S, Altice F, Muyoyeta M, Telisinghe L, Grandjean L, Keshavjee S, Andrews J. Scaling up evidence-based approaches to tuberculosis screening in prisons. The Lancet Public Health 2023, 8: e305-e310. PMID: 36780916, DOI: 10.1016/s2468-2667(23)00002-6.Commentaries, Editorials and LettersConceptsIncidence of tuberculosisCase-finding strategyHigh tuberculosis burdenMinistry of HealthEvidence-based approachTuberculosis burdenTreatment cascadeTuberculosis screeningTuberculosis notificationsTuberculosis diagnosisGeneral populationCare programDiagnostic strategiesTuberculosisEvidence baseSystematic screeningHigh rateIncidenceScreeningSetting
2022
How methadone becomes an intoxicant
Azbel L, Altice F. How methadone becomes an intoxicant. 2022, 203-220. DOI: 10.4324/9780429058141-17.Peer-Reviewed Original ResearchKyrgyz prisonsIntervention translationKyrgyz RepublicActor-network theoryEntire social groupsPractice of implementationGlobal evidence baseEvidence-based treatmentsParticipants' accountsAlternative enactmentsQualitative interviewsEvidence-based approachGlobal health communitySocial groupsOpioid useMaterial manifestationsPrisonHealth AccountsMethadone maintenance treatmentDistinct waysLocal networkMoral characterRepublicIntervention workPractice
2016
Police, Law Enforcement and HIV
Crofts N, Patterson D, Sidibé M, Crofts N, Patterson D, Footer K, Silberzahn B, Tormohlen K, Sherman S, Lunze K, Raj A, Cheng D, Quinn E, Lunze F, Liebschutz J, Bridden C, Walley A, Blokhina E, Krupitsky E, Samet J, Polonsky M, Azbel L, Wegman M, Izenberg J, Bachireddy C, Wickersham J, Dvoriak S, Altice F, Schneiders M, Weissman A, Kutsa O, Marcus R, Bojko M, Zelenev A, Mazhnaya A, Dvoriak S, Filippovych S, Altice F, Bhattacharjee P, Isac S, McClarty L, Mohan H, Maddur S, Jagannath S, Venkataramaiah B, Moses S, Blanchard J, Gurnani V, Ma Y, Du C, Cai T, Han Q, Yuan H, Luo T, Ren G, Mburu G, Wang B, Golichenko O, Zhang C, Mittal M, Beletsky L, Patiño E, Abramovitz D, Rocha T, Arredondo J, Bañuelos A, Rangel G, Strathdee S, Thomson N, Riley D, Bergenstrom A, Carpenter J, Zelitchenko A, Landsberg A, Kerr T, Milloy M, Dong H, Nguyen P, Wood E, Hayashi K, Lichtenstein B, Barber B, Group T, Scheibe A, Howell S, Müller A, Katumba M, Langen B, Artz L, Marks M. Police, Law Enforcement and HIV. Journal Of The International AIDS Society 2016, 19: 21260. DOI: 10.7448/ias.19.4.21260.Peer-Reviewed Original Research
2013
Optimizing Care for HIV-Infected People Who Use Drugs: Evidence-Based Approaches to Overcoming Healthcare Disparities
Meyer JP, Althoff AL, Altice FL. Optimizing Care for HIV-Infected People Who Use Drugs: Evidence-Based Approaches to Overcoming Healthcare Disparities. Clinical Infectious Diseases 2013, 57: 1309-1317. PMID: 23797288, PMCID: PMC3792721, DOI: 10.1093/cid/cit427.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsHuman immunodeficiency virusSubstance use disordersAntiretroviral therapyHealthcare disparitiesInitiation of ARTComorbid substance use disorderHIV treatment outcomesContinuum of careEvidence-based strategiesEvidence-based approachHIV specialistsHIV careHIV diagnosisImmunodeficiency virusTreatment outcomesUse disordersSubstance useCareDiagnosisDrugsOutcomesDisparitiesNegative outcomesTherapyEpidemiology
2009
Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market
Bruce RD, Govindasamy S, Sylla L, Kamarulzaman A, Altice FL. Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market. The American Journal Of Drug And Alcohol Abuse 2009, 35: 68-72. PMID: 19212931, PMCID: PMC2791788, DOI: 10.1080/00952990802585406.Peer-Reviewed Original ResearchConceptsBuprenorphine/naloxoneOpioid withdrawal symptomsSyringe sharingWithdrawal symptomsSnowball recruitment techniquesLogistic regression analysisDiversion of buprenorphineLack of reductionEvidence-based approachPrimary outcomeBuprenorphine injectionOnly symptomBenzodiazepine useBenzodiazepine injectionStomach painBuprenorphineInjection doseRisk behaviorsSymptomsNaloxoneInjectionRegression analysisNLXDaily amountDose